LifeArc Early Ventures
Funds early-stage life science ventures with seed and Series A equity across therapeutics and medical device innovation.
LifeArc Early Ventures is the equity investment arm of LifeArc, a UK self-funded medical research charity that translates laboratory discoveries into treatments for rare diseases and global health conditions. Operating as LifeArc Ventures, the programme provides Seed and Series A equity investment to early-stage life science companies, with the possibility of significant follow-on investment reserβ¦
Seed and Series A equity investment in early-stage life science companies across therapeutics, HealthTech, and medical devices within LifeArc's five disease focus areas.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides βGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereNon-Dilutive Funding vs VC for Deeptech Startups
Compare non-dilutive funding and venture capital for deeptech startups, including grants, SBIR/STTR, EIC Accelerator, dilution, timing, and stage fit.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
More from LifeArc
All grants from this funder βLifeArc Rare Disease Clinical Trials Programme
π¬π§LifeArc Β· United Kingdom
Supports clinical rare-disease teams with practical trial design and execution.
Drug Repurposing Call to Treat Chronic Respiratory Infection
π¬π§LifeArc Β· United Kingdom
Funds UK-led consortia repurposing drugs for bronchiectasis and cystic fibrosis.
LifeArc and Action Medical Research Fund
π¬π§LifeArc Β· United Kingdom
Co-funds UK translational research turning rare-disease science into treatments.
LifeArc Gene Therapy Innovation Fund
π¬π§LifeArc Β· United Kingdom
Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.
LifeArc KT Innovation Fellowship
π¬π§LifeArc Β· United Kingdom
Supports career fellowship for early career European life scientists entering technology transfer travel expenses only no stipend.
LifeArc Philanthropic Fund
π¬π§LifeArc Β· United Kingdom
Funds rare-disease therapeutics, devices and diagnostics from academics and early-stage spinout companies.
Similar grants
Browse the directory βParkinson's Research Ventures β Partnership Inquiry
Parkinson's UK Β· United Kingdom
Invests in Parkinson's drug discovery ventures through a global partnership route led with Parkinson's Foundation and Parkinson's United Kingdom.
SOSV NY (formerly IndieBio NY)
πΊπΈSOSV Β· United States
Invests in early-stage biology and life sciences startups and provides a six-month New York City residency.
Hub71+ Life Sciences Programme β Cohort 20
π¦πͺHub71 Β· United Arab Emirates
Supports biotech, medtech, and life sciences startups in Abu Dhabi through twelve-month acceleration.
Creative Destruction Lab (CDL)/27 Cohort
Creative Destruction Lab Β· Canada
Offers Creative Destruction Lab cohorts with mentorship, customer discovery, and venture readiness to help startups scale.
OCC Ventures
π¬π§Edinburgh Innovations Β· United Kingdom
Backs University of Edinburgh associated companies through OCC Ventures with seed and Series A co-investment.
Connecticut Bioscience Innovation Fund (CBIF)
πΊπΈConnecticut Innovations Β· United States
Invests in Connecticut bioscience and life-science ventures with additional grant routes for academic and nonprofit teams.